Reuters logo
BRIEF-Celgene's ESMO data further evaluates drug's potential to treat various cancers
September 8, 2017 / 12:13 PM / 3 months ago

BRIEF-Celgene's ESMO data further evaluates drug's potential to treat various cancers

Sept 8 (Reuters) - Celgene Corp

* Data presented at ESMO 2017 further evaluate role of Abraxane® for patients with historically challenging cancers Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below